Lymphoma Surgery

Lymphoma surgery is an uncommon treatment option in lymphomas. Despite all the advances in anti-cancer treatments over the past one hundred years—-radiation, chemotherapy, immunotherapy, targeted treatments, and more—-the single most common treatment for cancer patients, the one that brings about the highest cure rate across all cancers, remains the same as it always has been: Surgery.

Sometimes referred to as resection, surgery to remove solid tumors remains the top dog in cancer treatment. It is used to bring about cures and is also sometimes used in an exploratory fashion to determine the stage of a disease. However, this common procedure has virtually no place in the treatment of lymphoma.

Common procedures

The overwhelming majority of patients undergoing lymphoma treatment for several subtypes are likely to undergo no more than a one or two surgical procedures. Most will endure an excisional biopsy to remove a swollen lymph node for analysis by a qualified pathologist.

Even when a lymphoma patient presents with a bulky mass in the chest, for example, the mass is more likely to be treated with radiation and/or combination chemotherapy. While this is an invasive procedure, it is hardly on par with the procedures involved in other cancers to remove malignant tumors.

The other lymphoma surgery procedure, which is invasive but not surgical, is a bone marrow biopsy.

Success Rates

Despite the fact that resection (the most effective treatment in most cancers for bringing about cures) is extraordinarily uncommon in the treatment of lymphomas, over the past four decades the so-called blood cancers—-lymphoma and leukemia-—have enjoyed the biggest improvement in treatment successes and overall survival.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap